how to mix bpc-157 Peptides: Dose & [BPC-157] BPC-157/TB-500 BLEND PEPTIDE VIAL –

The purpose is to reduce the in vivo hemolytic toxicity and immunogenicity of exogenous AMPs, while retaining their anti-cancer activity, aiming to reduce the peptide dose required for treatment while ensuring safety

Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI , Nguyen-Tan PF, Fortin A, Silverman CL, Raben A, Kim HE, Horwitz EM, Read NE, Harris J, Wu Q, Le QT, Gillison ML

Simultaneously, KPV stabilizes IkB-alpha, the cytoplasmic inhibitor that keeps NF-kB inactive

The hepatic metabolism pathway for BPC-157 means the peptide passes through the liver where many medications are also processed

J Hepatol 74(5):12531254